Net shares · 365d
-445.4K
0 buy · 445.4K sell
Net value · 365d
-$1.6M
$0 in · $1.6M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
4
0 buy · 445.4K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
CLOV Sell·S
CEO, Counterpart Health · 10b5-1
$879.5K
220.4K sh · $3.99
Own -14%
-
CLOV Sell·S
CEO, Counterpart Health · 10b5-1
$693.0K
209.8K sh · $3.30 avg · 2 lots
Own -13%
-
CLOV Sell·S
CEO, Counterpart Health · 10b5-1
$49.6K
15.2K sh · $3.26
Own -1%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| May 28, 2026 | CLOV | Sell S | 220.4K | $879.5K |
| Jul 23, 2025 | CLOV | Sell S | 209.8K2 lots | $693.0K |
| Jul 8, 2025 | CLOV | Sell S | 15.2K | $49.6K |
Buy Sell Non-market (grant · exercise · gift)
About Wai Conrad
This profile aggregates every SEC Form 4 insider transaction reported by Wai Conrad across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.